A new study finds promise in a drug associated with significantly reduced hospitalizations among high-risk patients who received an injection in the early stages of COVID-19 infection.
A new study finds promise in a drug associated with significantly reduced hospitalizations among high-risk patients who received an injection in the early stages of COVID-19 infection.
Eiger BioPharmaceuticals reports positive phase 3 results for COVID-19 treatment pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.